Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.
Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check7 days agoChange DetectedNew Study Record Dates entries were added for 2025-12-03 (Actual) and 2025-12-05 (Actual), and entries for 2025-09-11/12 were removed. These changes are administrative in nature and do not affect trial details or outcomes.SummaryDifference0.3%
- Check14 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1. No changes to trial information or page content; this appears to be an internal site version update.SummaryDifference0.1%
- Check29 days agoChange DetectedRemoval of the government funding/operating status notice from the page; core study details, eligibility criteria, endpoints, and contacts remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check43 days agoChange DetectedAdministrative update to the study record reflecting the last update posted and QC criteria timestamp; no changes to eligibility, endpoints, enrollment, or treatment protocol. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%
Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.